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A Qualitative Meta-Analysis of Heart Failure Self-Care Practices among
Individuals with Multiple Comorbid Conditions
Abstract
Background
Most heart failure (HF) patients have other comorbid conditions. HF self-care requires medication and diet
adherence, daily weight monitoring, and a thoughtful response to symptoms when they occur. Self-care is
complicated when other chronic conditions have additional self-care requirements. The purpose of this study
is to explore how comorbidity influences HF self-care.
Methods
Using qualitative descriptive meta-analysis techniques, transcripts from 3 mixed methods studies (n = 99)
were reexamined to yield themes about perceptions about HF and self-care and to explore the influence on
HF self-care. The Charlson Comorbidity Index identified comorbid conditions.
Results
The sample was 74% Caucasian, 66% male (mean age of 59.6 years ± 15 years). Fifty-three percent of the
sample was New York Heart Association Class III. All had at least 1 other chronic condition. Narrative
accounts revealed that adherence to diet, symptom monitoring, and differentiating symptoms from multiple
conditions were the most challenging self-care skills. Emerging themes included 1) attitudes drive self-care
prioritization and 2) fragmented self-care instruction leads to poor self-care integration and self-care skill
deficits.
Conclusions
Individuals with multiple chronic conditions are vulnerable to poor self-care. Research testing coaching
interventions that integrate self-care requirements and focus on developing skill in self-care across multiple
chronic conditions is needed.
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self-care, heart failure, comorbidity
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Abstract 
Objective: To explore factors contributing to intentional and unintentional medication 
nonadherence in adults with chronic heart failure (HF). 
Background: Medication nonadherence is prevalent in HF but the factors contributing to it are 
not well understood. 
Methods: This secondary data analysis of qualitative data explored narrative accounts about 
medication adherence from four previous studies (N=112). The Necessity-Concerns-Framework 
derived from the Common Sense Model (CSM) of Self-Regulation guided the interpretation of 
themes. 
Results: In this diverse sample (39% Black, 6% Hispanic, 63% male; mean age 59 ±15 years), 
90% reported at least intermittent nonadherence. For many (60%), missing medication was 
unintentional but 27% reported intentional nonadherence. Four interconnected patterns of 
behavior emerged: 1) rarely nonadherent, 2) frequently nonadherent, 3) intentionally 
nonadherent, and 4) reformed nonadherent. Misperceptions about HF, beliefs, concerns, and 
contextual factors contributed to both intentional and unintentional nonadherence.  
Conclusion: Medication nonadherence is prevalent in HF and influenced by modifiable factors.  
 
Key words: medication adherence, self-care, common sense model, heart failure 
 
Abbreviations list: 
 HF, heart failure 
 CSM, Common Sense Model 
 NYHA, New York Heart Association  
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Introduction 
Medications are the single most important factor in slowing, arresting, and occasionally 
reversing chronic heart failure (HF). Yet, medication adherence is poor in adults with HF. These 
patients take, on average, 10 different medications daily, most with multiple doses required. 
Even among those with drug coverage insurance benefits, 40-60% adhere poorly to the 
prescribed regimen.
1
 Over time, full adherence to the regimen may be as low as 10%.
2
 
 
Medication adherence is defined as the extent to which medications are taken as prescribed.
3
 
Both intentional and unintentional factors contribute to nonadherence. Intentional nonadherence 
is deliberate discontinuing, skipping or reducing the dose of medication.
4, 5
 Factors known to 
contribute to such decisions include poor motivation, adverse side effects, perceived lack of 
effect, regimen complexity, being asymptomatic, individual perceptions (e.g., think the medicine 
is unnecessary) and poor health literacy.
6, 7
 Unintentional nonadherence is careless missing of 
doses or errors due to factors such as forgetfulness and poor understanding of the prescribed 
instructions that is largely driven by a lack of capacity or resources to take medications.
6
 The 
reasons underlying intentional and unintentional nonadherence may not be entirely independent 
in that certain types of unintentional nonadherence (e.g. forgetting) are logically more likely 
when patients are not motivated to take a medicine.
6
  
 
Medication nonadherence is known to be common in HF
8
 and nonadherence is strongly 
associated with HF outcomes.
9, 10
 However, we know surprisingly little about the reasons for 
nonadherence in HF patients. In other populations, reasons for nonadherence are known to vary 
for different medications and different illnesses,
11-13
 which highlights the importance of 
investigating nonadherence in subgroups of patients. Unintentional nonadherence is thought to 
be more common than intentional nonadherence,
14
 but these dimensions of nonadherence have 
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not been described in HF patients. Understanding the prevalence of and reasons for intentional 
and unintentional nonadherence can potentially contribute in important ways to the design of 
effective behavioral interventions to improve medication adherence.
15, 16
 Thus, the objective of 
this study was to explore factors contributing to intentional and unintentional medication 
nonadherence in a sample of adults with chronic HF.  
 
Theoretical Framework 
The Common Sense Model (CSM) of Illness Representation was developed as a way of 
conceptualizing poor patient adherence with health-promoting behaviors.
17, 18
 The CSM posits 
that illness perceptions (the illness label or diagnosis and associated symptoms), causes, timeline 
(acute, chronic or cyclical), consequences (social, monetary and health-related consequences of 
the illness and treatment) and control beliefs (the degree of control the patient thinks s/he has, the 
doctor has and the treatment has) affect behavior.
17, 19
 Building on the CSM, Horne
5
 developed 
the Necessity-Concerns-Framework (Figure), which specifies that medication adherence is a 
function an individual’s illness beliefs. Illness beliefs lead to concerns and questions about 
whether a drug is really necessary, which may cause intentional nonadherence. A significant 
proportion of individuals are concerned that medicines are harmful, unnatural, and better 
avoided.
20
 Horne notes that “unintentional nonadherence may be understood in terms of skills 
and abilities, whereas to understand intentional nonadherence we must consider patients’ 
motivation to initiate and persist with the treatment regimen”5 (p.67S). These elements of the 
Necessity-Concerns-Framework were used to explore intentional and unintentional factors 
contributing to medication nonadherence in adults with chronic HF.  
 
Methods 
This was a secondary analysis of qualitative data from four studies in the investigators’ programs 
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of HF self-care research. Secondary data analysis of qualitative data is a research strategy that 
makes use of existing qualitative data for the purposes of investigating new questions
21
 or 
applying a new perspective or conceptual focus to the existing research.
22
 There are numerous 
advantages to secondary data analysis of qualitative datasets
21
 including the ability to generate 
new knowledge or new hypotheses, or support existing theories while reducing human subject 
burden. Secondary data analysis of qualitative data also allows wider use of data from typically 
underrepresented research subjects.
23
  
 
A key premise of secondary data analysis is that there is a fit between the primary data sets and 
the new research question that includes similar data collection and analytic techniques.
23, 24
  In 
selecting datasets to include in a secondary data analysis, assessment of dataset quality, including 
depth or richness of data, is important to achieve answers to the proposed research question.
22
 In 
this secondary analysis, qualitative data from four completed studies were analyzed, all of which 
explored biobehavioral and sociocultural influences on self-care or tested an intervention to 
improve self-care. A sample of 125 individuals participated in one of the four prior studies; 
medication adherence was discussed by 112 of these participants (Table 1). The qualitative 
component of each prior study had been led by one of these authors (VVD), an experienced, 
highly trained qualitative methodologist. This investigator either personally interviewed 
participants or personally trained interviewers to collect the qualitative data. Each study 
complied with the Declaration of Helsinki, locally appointed ethics committees approved the 
research protocols, and informed consent was obtained from all participants.  
 
Each study used a series of similar open-ended questions (“Tell me about your heart failure” and 
“What do you do on a daily basis to take care of your heart failure?”) to elicit in-depth accounts 
of self-care. To gain insight into medication adherence, an essential component of HF self-care, 
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focused questions about medication taking were asked (“Tell me about your medication”). 
Nonadherence was defined liberally in this qualitative analysis as skipping medication doses or 
reducing doses taken on an intermittent or frequent basis, regardless of cause. A liberal definition 
was used because no objective measure of medication taking behavior was available. Thus, 
medication adherence was judged based on patient statements. Barriers and facilitators to 
medication adherence were elicited through a series of follow-up probes asking about caregiver 
support for adherence and perceptions about importance of medication taking. Thus data 
collection and analytic techniques across studies were assured; and in-depth narratives about 
medication adherence provided for a rich qualitative dataset for this secondary analysis. 
 
Qualitative Data Analysis 
The qualitative data from these four studies were analyzed in a systematic manner using thematic 
content analysis.
25, 26
 The steps of analysis are detailed in Table 2. This process yielded a rich 
description and over 400 coded data segments about medication adherence. Individual findings 
were first reviewed first at the level of codes, focusing on the categories and themes originally 
coded as related to the medication adherence. Qualitative data were re-examined and re-coded by 
a single investigator (VVD) as reports of intentional and unintentional medication nonadherence. 
Next, qualitative accounts of medication nonadherence were explored and organized within the 
theoretical context of the Necessity-Concerns-Framework. Finally, the pattern of themes was 
reviewed across studies. This within-study and across-study analysis was an iterative process 
involving a reanalysis of the original raw data and a reinterpretation of previous findings to 
answer additional questions about intentional and unintentional contributors to medication 
nonadherence. 
 
Methodological rigor of the qualitative analysis was maintained through an audit trail, periodic 
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debriefing with the co-investigator and discussions with colleagues knowledgeable about HF, 
medication adherence, and the Necessity-Concerns-Framework. Reliability was measured by 
consistency of interpretation and coding.
27
 An audit trail of process and analytic memos and 
coding books was maintained to support the credibility of the study.  
Results 
Sample demographic and clinical characteristics are shown in Table 3. The final sample 
consisted of 112 participants; 41 (37%) were women. Ages ranged from 25 to 98 years (mean 
age 59±15 years) with almost half (46%) older than 60 years. Most (58%) participants were 
White and most had New York Heart Association (NYHA) class II (41%) or class III (55%) HF. 
In this sample, 90% admitted to some amount of medication nonadherence. For many (60%), 
missing medication was unintentional and most commonly due to forgetfulness but 27% (n=30) 
admitted to intentionally skipping medication doses. Distinct patterns of behavior were evident. 
 
Illness Perceptions and Perceived Need 
Participants discussed experiencing typical HF symptoms including weight gain (43%), ankle 
swelling (50%), shortness of breath (54%), and fatigue (74%), but they did not always interpret 
these symptoms as related to HF. Symptom interpretation was based on prior experience and the 
severity of symptoms. For example, most recognized symptoms like weight gain, ankle swelling 
and breathing problems as related to fluid retention and linked to HF (“I get short of breath, I 
know the fluid is backing up in the lungs and I could end up in the hospital again.”). Episodic 
weight gains and ankle edema, which signaled fluid retention, prompted the need to take an extra 
diuretic. Interpretation of symptoms as HF-related reinforced the importance of routinely taking 
medication. As one 42 year old White woman explained, “I feel better when I take my 
medicines…my ankles don’t swell, I don’t retain fluid…so I ALWAYS take my medication.” 
Similarly, several described how the acute onset of symptoms like shortness of breath or chest 
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pain signaled worsening HF and prompted medication taking to alleviate the symptom.  
 
Fatigue and lack of energy, although mentioned by 74% of participants, were less often 
interpreted as HF-related. Many in this sample reported having a chronic, vague symptom like 
feeling tired, which they “have to get used to” rather than a symptom that can be managed with 
medication. Thus, the importance of medication to the management of these symptoms was 
rarely mentioned. In a very few cases (n=5), vague symptoms were recognized as representing 
HF and alleviated by medications; these patients knew that taking medication regularly was 
important. A 45 year old White male described the importance of his medication as, “My heart 
failure symptom is fatigue…probably the primary…I take my medication and I feel better…more 
energy…” These results suggest that symptom recognition and interpretation influence the 
perception of HF as a serious illness requiring medications.   
 
Situational nonadherence was most frequently described by those who perceived HF as a low 
threat condition. In these cases, deliberate cognitive (“one day I forgot and there was no 
difference in how I felt…”) and emotional (“…so if I am going to be out with my friends…I don’t 
want to carry the pillbox…”) processes were described as influencing actions. The pros and cons 
of taking medication were appraised, providing a rationale to the decision to purposively “skip 
medication”. Certain situations like travel, vacation, work or family events outweighed the 
perceived need for medication.  
 
Background Beliefs 
When HF was perceived as inconsequential, negative attitudes regarding the importance of the 
medication regimen influenced adherence. Those who believed that the medication was either 
not helpful (“I was taking all these…10 pills … for years. In my opinion, they were not doing 
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anything…so I stopped taking them…”) or in conflict with their personal preferences (“I have 
always hated taking pills…so I skip them some days…”) questioned necessity and purposively 
missed doses.  
 
A subset described intentional nonadherence as a means of regaining control over their life and 
illness. In these narratives, loss of personal control was described. As one 51 year old Black male 
described, “…sometimes I don’t take all of them…I used to be very active so if I take them I can’t 
do what I want… sometimes, I just want to feel like myself again…I want to feel normal.”  
 
Concerns 
Complex regimens highlighted concerns about potential dangers. Many of these participants had 
multiple conditions and complex regimens (“I think it is too much… I think <HF medication> 
makes the sugar low and when the sugar’s low…that I know is very bad”). As a result, some 
reported only taking the medications they perceived as most necessary.  
 
Other concerns were linked to past experiences. Undesirable side effects of HF medications were 
reported by 17 (15%) individuals and these negative past experiences (“…I don’t want to end up 
having that problem again on the plane…”) outweighed perceived benefits of medication. In 
addition, lack of knowledge about how to manage a missed dose generated concerns about 
potential dangers (“When I remember it, I worry about what to do…will it be like a double dose 
if I take it too late…”). Those without strategies to deal with such situations were vulnerable to 
medication nonadherence.   
 
Concerns about physical and mental wellbeing resulted in unintentional nonadherence for some. 
Sleeping too much and feeling fatigued resulted in missed doses (“I slept too long and missed the 
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time for my pills”). Being depressed resulted in missed doses because of feeling unable to 
execute the behavior. One 74 year old White woman described that she always takes her 
medication with food so when she does not “feel strong enough to cook”, she may wait to take 
her medication “until I feel better”. 
 
Contextual Issues 
A variety of contextual issues influenced adherence in positive and negative ways. Instructions 
from healthcare providers about symptoms (“<doctor> told me to watch and if I get short of 
breath…”) and social supporters/caregivers (“<wife> knows before I do that <HF> is worse”) 
helped patients recognize and interpret their symptoms as HF-related. Cues such as pill boxes or 
calendars noting medication schedules helped them incorporate pill taking into their daily 
routines (“the pill box is by the coffee…for years I have been getting my cup of coffee…now I 
take my pills and get my coffee…). Other contextual cues included reminders from caregivers 
(“wife’s the boss…she puts the pills in my hands and makes sure I take them ALL…) or the 
healthcare system (e.g., automatic pharmacy renewals). These environmental stimuli supported 
the perception of HF as a threat (“It’s not hard to take those pills each morning…I chose to 
live”) but one that is controllable (“this cocktail of pills that I am on is the best there is for my 
condition”). However, when there was an unplanned break in the daily routine (“we had visitors 
so I put the pillbox away…”), a gap in support (e.g., a family member not being available to refill 
the pill box), or an event (e.g., vacation, travel) that altered schedules, medication doses were 
more likely to be missed. 
 
Fragmented care emerged as an important contributor affecting patients’ adherence. For 
example, when a healthcare provider failed to refill a prescription after a hospitalization or gave 
conflicting prescriptive information, medication doses were missed. One 65 year old Black male 
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described his concern over missing his diuretic since a recent hospitalization… (“…this doctor 
here missed it…I know I was on a water pill because I noticed before I was passing water more 
than what I am now…I think I should be on it…but they missed it…”). For some, inadequate 
financial resources such as lack of insurance or pharmacy access made it difficult to obtain 
medication (“there’s no pharmacy here that takes my Medicaid, so they tell me to go to 
<pharmacy chain>. There’s no <pharmacy chain> in my neighborhood…”) or required that 
choices be made about which medication to take (“…If they cost too much…I don’t take them…I 
can’t”). 
 
Patterns of Medication Nonadherence 
Four patterns of nonadherence emerged that help explain the complexity of medication 
adherence and provide important implications for intervention. Guided by the CSM, these four 
patterns elucidate the relative contribution of illness perceptions, beliefs, concerns, and 
contextual issues on the outcome of medication nonadherence.  
 
Rarely Nonadherent 
Twenty-five (22%) individuals described being adherent most of the time and missing 
medication only on rare occasions. These participants had no pattern of recurrent nonadherence 
or intentionally skipping medications. Their representation of HF was as an illness that was “life-
threatening” but controllable with medication. Most of these reported adequate access to 
healthcare services and providers who had educated them about their medicines, including how 
to manage a missed dose. As a result, they had structured routines in place to consistently adhere 
to even complex regimens and systems for managing missed doses when they occurred. They 
described routines and cues to help them remember medicines and had positive attitudes about 
the importance of their medicines.  
12 
 
Frequently Nonadherent 
The second pattern was frequent nonadherence, but this nonadherence was unintentional. These 
participants (n=57, 51%) reported recurrent or routine nonadherence or patterns of nonadherence 
that could be linked to a situation or event (e.g., running out of medication). These situations 
caused them to forget on a regular basis. Although they described HF as a serious threat and 
noted the importance of medication, they routinely forgot to take doses and did not have 
effective cues or supports in place to facilitate adherence. Nor did they know how to manage 
missed doses. They described complicated regimens and other chronic conditions that made 
coping difficult. Importantly, they realized that their nonadherence was having negative health 
effects. They wanted to be better at taking medicines but did not have adequate knowledge or 
effective support in place to help them do so.   
 
Intentionally Nonadherent 
Twenty-one (19%) individuals described that they were intentionally nonadherent on a regular 
basis. They described purposively skipping medication and were likely to continue to do so. 
They perceived HF as either low threat or they had negative attitudes about medication necessity. 
They described a dislike of medication taking, medication side effects, or past negative 
experiences with side effects that influenced their behavior. Interestingly, medication adherence 
was described as an act of personal choice, and for some, a means of regaining personal control. 
Nonadherence was situational and varied based on the day’s events (work, vacation) and 
personal preferences (e.g., “If I just don’t feel like taking <pill> today...I don’t”). Further, they 
appraised their action of nonadherence as successful. One woman described that her husband, a 
71 year old White patient with HF, “has this idea that he does not need to take his medicine 
every day”. The husband explained, “…when I skip them…I don’t feel differently…so I don’t 
think I need them”.  
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Reformed Nonadherent 
Nine individuals (8%) reported past nonadherence that was intentional and driven by negative 
attitudes and an attribution of low perceived threat of HF. However, a negative experience (“I 
was near death”) reframed their HF illness perceptions and reinforced the importance of 
medication. In these cases, intentional nonadherence was appraised as unsuccessful, which 
prompted a change in action. Through education and communication by healthcare providers 
(“…<doctor> said straighten up…you are going to die from this….”) and the adoption of 
strategies to reinforce adherence, they described a new commitment to taking medication “as I 
am supposed to do not whether I want to or not”. Ongoing appraisal of success reinforced the 
importance of medication adherence. As a 57 year old Hispanic woman described, “…that was 
the scariest day because I decided that I had nothing wrong with me and I had stopped taking all 
of the medications….I ended up here and I was real bad… I learned that it’s (sic HF) gonna be 
with me for a long time…I learned that I have to take my medication…so I do now and I haven’t 
been back here since…no more scary days.”   
Discussion 
Medication nonadherence is recognized as a common and important problem in HF but the 
reasons contributing to the behavior are inadequately understood. Previous investigators have 
described many of the intentional and unintentional factors contributing to nonadherence, but in 
this study qualitative data from a substantial sample of adults with chronic HF were used to 
explore the contribution of the Necessity-Concerns-Framework to our understanding of these 
factors. Ninety percent of the sample reported being nonadherent at least intermittently. For 
many (60%), missing medication was unintentional and most commonly due to forgetfulness, but 
27% reported intentional nonadherence. Four patterns of behavior were identified: 1) rarely 
nonadherent, 2) frequently nonadherent, 3) intentionally nonadherent, and 4) reformed 
nonadherent. Misperceptions about HF, beliefs, concerns, and contextual factors contributed to 
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both intentional and unintentional medication nonadherence in these HF patients. 
 
Others have also found that forgetting is the major reason for nonadherence in HF patients. 
Aggarwal et al reported that 60% of patients reported sometimes forgetting to take their 
medications.
28
 This finding suggests that interventions that augment prospective memory may 
decrease unintentional nonadherence. Prospective memory refers to the capacity to form, 
maintain, and execute an intention to perform a behavior at a particular point in the future.
29
 
Intention (e.g., the intention to take a medication) initiates a process of monitoring for cues (e.g., 
a pill bottle), detecting cues, recalling the intention and then executing the behavior. That is, in 
patients who intend to take a medication, the conscious recollection of the planned event will 
stimulate pill taking. However, deficits in prospective memory are unlikely to factor into 
nonadherence if the patient has no intention of taking the pill (intentional nonadherence). This 
distinction illustrates the importance of understanding the reasons underlying medication 
nonadherence. 
 
Knowledge, attitudes and beliefs influence illness perceptions and adherence. An important 
knowledge deficit in these patients was failure to recognize fatigue as a symptom of HF, so this 
symptom did not motivate medication adherence. This finding is similar to that of Horowitz et 
al
30
 who found that patients who misattributed their symptoms to aging were ineffective in 
managing their HF. These results suggest that the symptom of fatigue is vague to patients and 
warrants concerted attention during HF education sessions. Another knowledge deficit was in 
what to do if a medication dose is forgotten. Our finding that HF patients are uncertain about 
how to handle this situation is consistent with those of others who found that worrying and 
uncertainty were common in adults with diabetes experiencing insulin dosing problems.
31
 
Handling a missed dose is clearly a situational skill that needs to be emphasized in teaching 
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sessions.  
 
An important belief with a powerful influence on adherence was the misconception that HF is 
not a threatening illness; individuals with this belief were likely to be intermittently nonadherent, 
at least until a hospitalization occurred. If 90% of patients admitted to some amount of 
nonadherence, a number consistent with early research in this area,
2
 it seems safe to assume that 
any HF patient admitted to the hospital unexpectedly should be engaged in a discussion of 
medication adherence. After hospitalization, some intentionally nonadherent patients became 
“reformed” and attended carefully to medication adherence. This finding supports the theoretical 
framework, which proposes that changes in cognitions produce changes in coping attempts.
32
 
That is, as these patients became convinced that HF was life-threatening and medication could 
help, they became more adherent.  
 
Concerns related to mood and regimen complexity interfered with adherence, as others have 
found.
33-35
 The concern that may be less appreciated is loss of control. Although perceived 
control is known to predict adherence to diet and exercise, less is known about perceived control 
in relation to medication adherence. Quine and colleagues
36
 identified perceived control as one 
of the leading predictors of medication nonadherence in a sample prescribed anti-hypertensive 
medications. In an earlier study, Piguet et al
37
 found that persons with chronic pain who were 
prescribed antidepressants reported effects on cognition, emotions, and personality, which 
induced feelings of dependence and loss of control. A loss of control led to ambivalence about 
taking the antidepressants and contributed to nonadherence. Exploring these concerns with 
patients may reveal issues for further discussion. 
 
Contextual issues such as provider and automatic pharmacy renewal mistakes contributed in 
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important ways to nonadherence. Fragmented care, medication cost, and side-effects were all 
factors, a finding similar to that of Laba et al
38
 who studied Australian adults prescribed 
medications for a diverse range of chronic conditions. They found that side effects and high cost 
were interpreted by patients as poor treatment decisions by providers, which contributed to 
nonadherence. Schuz and colleagues
39
 suggested that if older people with multiple illnesses are 
convinced that their medication serves their specific needs, they are likely to be adherent. But if 
doctors prescribe too many medications, those with unacceptable side-effect profiles, or 
expensive medications, patients are more likely to be nonadherent. Providers may not realize that 
patients judge the quality of the care they receive at least partially based on the medications 
prescribed. Our results illustrate that failure to discuss cost, side-effects, and the reason for 
prescribing a medication, risk nonadherence that is potentially preventable.  
 
This study was strengthened by the use of qualitative secondary analysis techniques and the 
relatively large sample size. However, several limitations need to be acknowledged. In each of 
the four original studies, similar general questions were used to gather accounts of self-care and 
fidelity to the interview guide was monitored. Three of the four studies were descriptive but one 
was an intervention study testing motivational interviewing.
40
 In that study, these general 
questions were embedded within the intervention interview, but they were still the same 
questions. In a secondary data analysis such as this, the data rely on what was captured in the 
primary studies. Therefore, contradictory accounts of medication adherence that were not 
clarified at the time of the original interview required that discrepancies be resolved within the 
analysis process by determining the predominant theme in the transcribed data through content 
analysis. Another potential limitation is that we relied on subjective reports of medication 
adherence rather than objective measures. This led to subjective definitions of nonadherence. 
That is, we were not able to quantify the number of missed doses so nonadherence was defined 
17 
 
based on participant reports. 
 
Implications for Practice  
Implications include recognition that intentional and unintentional nonadherence are distinct 
phenomena, predicted by different factors, as others have noted.
39, 41
 Thus, interventions need to 
target the issues underlying each individual’s behavior. Considering the patterns identified, 
rarely nonadherent patients need only reinforcement and encouragement.  
 
Those in the frequently nonadherent group have illness perceptions that are already appropriate 
(i.e., HF is a serious illness and medications are important), but medicines are routinely 
forgotten. They need interventions that address both knowledge (e.g., what a drug does) and 
action-planning (e.g., when to take it). Interventions for these two different memory problems 
differ. Patients who cannot remember what a drug is for need brief descriptions they can refer to 
while those who cannot remember to take a drug need memory triggers and a way to check 
whether or not they took it (e.g. a pillbox). Communication between providers at different 
settings (e.g. inpatients and outpatient settings) is essential when a patient is identified as 
frequently nonadherent. Education should include how to deal with missed doses. Most 
pharmacies have patient instructions for "What to do if I forget a dose or if I cannot recall if I 
took my medication" that should be provided routinely. Caregivers might be engaged to assist 
these patients to remember medications and should be provided with easy to understand 
information about the medications. In addition, role-playing exercises that facilitate problem 
solving and experiential learning may be useful.
42
 Identification of concerns (e.g., perceived loss 
of control) may reveal other targets for intervention.  
 
The intentionally nonadherent patients need the most attention. Assessment of the symptom 
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pattern may reveal a reason for nonadherence. Interventions should address knowledge, beliefs, 
and attitudes influencing illness perceptions using a strategy like motivational interviewing or 
another approach that addresses behavioral intention. The reformed nonadherent patients might 
be engaged to talk with the intentionally nonadherent patients about their experiences, as the 
reformed patients were intentionally nonadherent in the past. Further research is needed to 
confirm the behavioral patterns and to test the efficacy of these suggested interventions.  
 
In summary, 90% of the sample reported being at least intermittently nonadherent. Most 
nonadherence is unintentional and due to forgetfulness, but a significant proportion of HF 
patients are intentionally nonadherent. Four patterns of behavior were described with specific 
interventions suggested for each pattern. Misconceptions about HF, beliefs, concerns, and 
contextual factors contribute to both intentional and unintentional nonadherence. The implication 
for health care professionals is to suspect intermittent nonadherence and address misconceptions, 
beliefs, and concerns as one way to improve adherence in this population of patients. 
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  Figure Legend: The figure illustrates that illness perceptions influence patients’ perceived need for a 
medication. If a drug is thought to be needed, medication adherence is likely. Individual beliefs and 
concerns greatly influence adherence. Even if the individual intends to adhere to the medication 
regimen, contextual factors such as finances may interfere with medication adherence.  
 
Adapted from Horne6 with permission.  
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Table 1: Description of studies used in this secondary analysis 
Study  Purpose Sample Demographics 
Dickson et al 
43
 To examine the contribution 
of attitudes, self-efficacy, and 
cognition to HF self-care 
among non-elder patients 
with HF 
N= 41 63% male,  
68% White;  
Mean age 49.2( 10.51) years; 
58.5% NYHA III 
 
Riegel et al 
44
 To explore age-related 
differences in the ability to 
perceive symptoms of HF 
N=29; 72% Male; 100% born in 
Australia of European or Asian 
parentage; Mean age 68.7(14.4) 
years; 58.6% NYHA II 
 
Riegel et al 
40
 To assess the influence of 
motivational interviewing on 
self-care of adults with HF 
N=25; 64% Male 
75% White 
Mean age 63(11) years; 
53% NYHA II 
Dickson et al 
45
 To describe socio-cultural 
influences of HF self-care 
among ethnic minority 
population 
N=30, 60% male,  
100% Black;  
Mean age 59.6(±15.2) years;  
67% NYHA III 
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Table 2. Detailed description of the steps used in analysis 
Steps in Analysis Example 
Sorting the primary data  Reviewed the qualitative data files and analysis files in 
Atlas.ti (e.g., memos, code books, etc.) 
 Identified data to exclude (i.e., no mention of medication) 
Identify codes and themes 
related to the new research 
question 
 Identified codes: medication, medicines, adherence, 
nonadherence, self-care maintenance and their co-
occurring codes (e.g., symptoms, side-effects, cost). 
 Developed new codes 
 Categorized codes and themes as intentional (e.g., cost) or 
unintentional (e.g., forgetfulness). 
Analyze original data and 
clarify interpretations 
 Re-examined the original data, identifying intentional or 
unintentional medication adherence. Additional coded 
segments added to analysis. 
 Explored coded data within the context of Necessity-
Concerns-Framework: For example, illness perceptions 
(e.g., fatigue not linked to HF). 
 Identified patterns of medication nonadherence and the 
contextual factors influencing adherence (e.g., social 
support, finances) for each case (n=112).  
Interpretation   Synthesized the findings into 4 interconnected patterns of 
behaviors: rarely nonadherent, frequently nonadherent, 
intentionally nonadherent and reformed nonadherent; 
describe the characteristics of each pattern. 
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 Reviewed these patterns within and across cases. 
Translation of findings  Translated these findings within the context of Necessity-
Concerns-Framework. For example, symptom 
interpretation influenced HF illness perceptions and 
perceived need for medication.  
 
HF = heart failure 
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Table 3: Sociodemographic and clinical characteristics of the sample 
Demographic Characteristics N=112 
M(SD) 
Age 58.9 (SD 15) 
 N/% 
Gender 
 Male 
 
71 (63%) 
Race 
 White 
 Black 
 Asian 
 
65 (58%) 
44 (39%) 
3 (3%) 
Ethnicity 
 Hispanic 
 
7 (6%) 
Marital Status (based on n=111) 
 Single, never married 
 Married or cohabitating 
 Widowed/Divorced/Separated 
 
41 (37%) 
48 (43%) 
22 (20%) 
Education (based on n=107) 
 Less than high school 
 High school graduate 
 College 
 
20 (18%) 
40 (36%) 
51 (46%) 
Clinical Characteristics M(SD) 
Years with HF (based on n=111) 5.3 (SD 5.3) 
Ejection Fraction (based on n=85) 32.7 (SD 16.2)  
 N/% 
NYHA Class (based on n=111) 
Class II 
Class III 
Class IV 
 
45 (41%) 
61 (55%) 
5 (5%) 
Type of HF (based on n=81)  
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 Systolic/Mixed 
 Diastolic 
105 (94%) 
   7 (6%) 
SD: standard deviation; HF: heart failure; NYHA: New York Heart Association 
 
 
 
